Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A regulatory system for use in gene transfer

Y Wang1, B W O'Malley, S Y Tsai

  • 1Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030.

Proceedings of the National Academy of Sciences of the United States of America
|August 16, 1994
PubMed
Summary

Scientists created a novel gene-switch system using a modified progesterone receptor. This system allows precise control of gene expression in response to RU 486, a progesterone antagonist, with potential applications in gene therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells.

Molecular and cellular biology·2001
Same author

Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.

The Laryngoscope·2001
Same author

Combination nonviral cytokine gene therapy for head and neck cancer.

The Laryngoscope·2001
Same author

Gene expression in the mammalian cochlea: a study of multiple vector systems.

Acta oto-laryngologica·2001
Same author

Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system.

Cell death and differentiation·2001
Same author

From ligand to response: generating diversity in nuclear receptor coregulator function.

The Journal of steroid biochemistry and molecular biology·2001

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Gene Regulation

Background:

  • A modified human progesterone receptor (hPRB891) binds antagonists like RU 486 but not progesterone.
  • This mutant receptor can activate transcription in the presence of antagonists.

Purpose of the Study:

  • To develop a novel, controllable gene-regulatory system.
  • To create a chimeric regulator for inducible gene expression.

Main Methods:

  • Constructed a chimeric regulator (pGL-VP) by fusing hPRB891 ligand-binding domain with GAL4 DNA-binding and VP16 activation domains.
  • Utilized transient transfection assays to test gene activation.
  • Validated the system in vivo using ex vivo transplantation in rats.

Main Results:

Related Experiment Videos

  • The chimeric regulator activated target genes containing GAL4-binding sites in response to RU 486.
  • The system demonstrated effective gene regulation in a mammalian model.
  • RU 486 was effective at significantly lower doses than required for progesterone antagonism.

Conclusions:

  • The developed gene-switch system offers precise, exogenous compound-controlled gene activation.
  • This system holds promise for gene-transfer applications in both animal models and humans.
  • The system allows specific "on/off" control of delivered genes.